June 01, 2007
DDMAC says Ciprodex sales aid omits facts
The FDA’s DDMAC says a retail sell sheet and sales aid for Alcon Laboratories’ Ciprodex omits material facts about the drug, including some risk information and limits to its indication.
The pharma company manufactures the well-known opioid OxyContin.
FDA Commissioner Dr. Scott Gottlieb has been saying all the right things regarding digital health.
Although if approved, it's not likely to launch in the U.S. for quite some time.